← Open Payments lookup

KELSEY STAPLETON: Open Payments

NPI 1609364785 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,229 in 141 payments from 24 companies in 2025. Trend: 2023 $1,999 · 2024 $2,066 · 2025 $2,229

Food & beverage: $2,229
CompanyPaymentsAmount
ABBVIE INC.37$465
Novo Nordisk Inc16$251
AstraZeneca Pharmaceuticals LP9$222
Amgen Inc.25$206
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$194
Astellas Pharma US Inc4$96
Axsome Therapeutics, Inc.5$91
Novartis Pharmaceuticals Corporation4$83
PFIZER INC.5$74
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$73

Products named: CAPLYTA, UBRELVY, OTEZLA, AIRSUPRA, QULIPTA, Rybelsus, VRAYLAR, Veozah.

Industry payments across VA — which companies pay providers there.